Otto Bock France SNC
7
1
1
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 7 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
20%
1 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (7)
EXOPULSE Suit and Walking Ability of Patients With Multiple Sclerosis
Role: lead
Study on a Prosthetic Foot With Adjustable Heel Height
Role: lead
Retrospective Study on the WalkOn AFO in Children or Teenagers With Neurological Pathologies
Role: lead
C-BRACE Versus SCO in Community Ambulators
Role: lead
Effectiveness of Ottobock Helmet Therapy in Infants With Plagiocephaly, Brachycephaly or Combination of Both
Role: lead
Compensatory Movements With Axon-Hook and Greifer in Transradial Amputees
Role: lead
Assessment of Disability Compensation With the C-LEG COMPACT 2 Knee (Ref. 3C60 et 3C60=ST)
Role: lead
All 7 trials loaded